Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1996 1
1998 1
2001 1
2003 1
2004 1
2005 1
2007 2
2008 1
2009 1
2011 3
2012 3
2013 4
2014 4
2015 6
2016 6
2017 3
2018 3
2019 5
2021 3
2022 5
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Lung Squamous Cell Carcinoma"
Page 1
Pembrolizumab-induced agranulocytosis.
Fernández Martínez V, García-Avello Fernández-Cueto A, Valencia Soto CM, Barbadillo Villanueva S, Ochagavía Sufrategui M, Rioja Carrera M, Alonso Buznego LA, Valero Domínguez M. Fernández Martínez V, et al. J Oncol Pharm Pract. 2024 Jun;30(4):767-771. doi: 10.1177/10781552241228774. Epub 2024 Jan 30. J Oncol Pharm Pract. 2024. PMID: 38291678
CASE REPORT: We report the case of a man diagnosed with non-keratinizing squamous lung carcinoma stage IVB with programmed death-ligand 1 70% who developed agranulocytosis 10 days after a single dose of pembrolizumab as monotherapy. ...Depending on bone marro …
CASE REPORT: We report the case of a man diagnosed with non-keratinizing squamous lung carcinoma stage IVB with program …
NUT carcinoma of the lung.
Lantuejoul S, Pissaloux D, Ferretti GR, McLeer A. Lantuejoul S, et al. Semin Diagn Pathol. 2021 Sep;38(5):72-82. doi: 10.1053/j.semdp.2021.06.005. Epub 2021 Jun 16. Semin Diagn Pathol. 2021. PMID: 34176698 Review.
The differential diagnoses include basaloid carcinoma of the lung, small cell carcinoma, thymic carcinoma (basaloid variant), SMARCA4_deficient thoracic sarcoma, other NUTM1 rearranged undifferentiated tumors, small round cell tumors, non …
The differential diagnoses include basaloid carcinoma of the lung, small cell carcinoma, thymic carcinoma …
Emphasizing on heat shock protein 90's utility in head and neck squamous cell carcinoma treatment.
Routray S, Sunkavalli A, Swain N, Shankar AA. Routray S, et al. J Cancer Res Ther. 2013 Oct-Dec;9(4):583-6. doi: 10.4103/0973-1482.126451. J Cancer Res Ther. 2013. PMID: 24518700 Free article. Review.
Clinically, encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma using the first generation Hsp90 inhibitors. ...Our review emphasizes it …
Clinically, encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non- …
Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis.
Vermeer DW, Coppock JD, Zeng E, Lee KM, Spanos WC, Onken MD, Uppaluri R, Lee JH, Vermeer PD. Vermeer DW, et al. Oncotarget. 2016 Apr 26;7(17):24194-207. doi: 10.18632/oncotarget.8254. Oncotarget. 2016. PMID: 27013584 Free PMC article.
Human papillomavirus induced (HPV+) cancer incidence is rapidly rising, comprising 60-80% of oropharyngeal squamous cell carcinomas (OPSCCs); while rare, recurrent/metastatic disease accounts for nearly all related deaths. ...We characterize an immune competent recu …
Human papillomavirus induced (HPV+) cancer incidence is rapidly rising, comprising 60-80% of oropharyngeal squamous cell carci …
Large-cell Neuroendocrine Carcinoma of the Lung with Carcinoid Syndrome.
Yamamoto M, Ito R, Tsujibata A, Morita H, Yoneda T, Matano Y, Higashikata T. Yamamoto M, et al. Intern Med. 2023 May 15;62(10):1557-1563. doi: 10.2169/internalmedicine.0099-22. Epub 2022 Oct 5. Intern Med. 2023. PMID: 36198589 Free PMC article.
Urine 5-Hydroxy indol acetic acid was markedly elevated. A liver biopsy revealed large-cell neuroendocrine carcinoma with serotonin production, suggestive of a lung origin, and a lung biopsy revealed combined large-cell neuroendocrine carcino …
Urine 5-Hydroxy indol acetic acid was markedly elevated. A liver biopsy revealed large-cell neuroendocrine carcinoma with sero …
Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma.
Tewari KS. Tewari KS. J Clin Oncol. 2019 Jun 10;37(17):1449-1454. doi: 10.1200/JCO.19.00119. Epub 2019 Apr 26. J Clin Oncol. 2019. PMID: 31026210 Review.
Biopsy revealed poorly differentiated, squamous cell carcinoma. Bimanual pelvic and rectovaginal examination, as well as radiographic imaging studies, were consistent with an International Federation of Gynecology and Obstetrics (FIGO) stage IB3 squamous …
Biopsy revealed poorly differentiated, squamous cell carcinoma. Bimanual pelvic and rectovaginal examination, as well a …
Squamous Cell Lung Carcinoma Presenting With Refractory Status Epilepticus: A Case Report of Paraneoplastic Limbic Encephalitis.
Hurley K, Herron M, McDermott S, Farrell T, O'Riordan D. Hurley K, et al. Respir Care. 2015 Aug;60(8):e144-7. doi: 10.4187/respcare.03879. Epub 2015 Mar 17. Respir Care. 2015. PMID: 25784771 Free article.
Histopathology confirmed the tissue diagnosis as squamous cell cancer. Initial immunotherapy with steroids and intravenous immunoglobulin and subsequent lobectomy and adjuvant chemotherapy were partially successful, leading to partial resolution of his cognitive imp …
Histopathology confirmed the tissue diagnosis as squamous cell cancer. Initial immunotherapy with steroids and intravenous imm …
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
[No authors listed] [No authors listed] Drugs R D. 2007;8(3):176-87. doi: 10.2165/00126839-200708030-00005. Drugs R D. 2007. PMID: 17472413 Review.
Introgen had presented combined results from three multicentre (US and Europe) phase II studies of INGN 201 in 217 patients with recurrent squamous cell carcinoma of the head and neck confirming previous safety and efficacy results of the treatment. In April …
Introgen had presented combined results from three multicentre (US and Europe) phase II studies of INGN 201 in 217 patients with recurrent …
Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients.
Zhang Q, Zhu L, Zhang J. Zhang Q, et al. BMC Cancer. 2015 Mar 1;15:88. doi: 10.1186/s12885-015-1056-9. BMC Cancer. 2015. PMID: 25886585 Free PMC article.
BACKGROUND: Although new individual treatments continue to reshape the landscape of clinical care in patients with lung cancer, most of the progress has been mainly of benefit to patients with lung adenocarcinomas rather than squamous cell lung …
BACKGROUND: Although new individual treatments continue to reshape the landscape of clinical care in patients with lung cancer, most …
Esophago-tracheobronchial fistula following treatment of anlotinib in advanced squamous cell lung cancer: Two case reports.
Zhang PL, Liu ZJ. Zhang PL, et al. Medicine (Baltimore). 2019 Nov;98(44):e17700. doi: 10.1097/MD.0000000000017700. Medicine (Baltimore). 2019. PMID: 31689797 Free PMC article.
PATIENT CONCERNS: Two squamous cell lung cancer patients with mediastinal metastasis undergoing the treatment of anlotinib developed clinical symptom of cough, which was worse upon ingestion. ...LESSONS: These 2 cases imply that a close follow-up schedule for …
PATIENT CONCERNS: Two squamous cell lung cancer patients with mediastinal metastasis undergoing the treatment of anloti …
55 results